InsiderClue
Stocks · Health care · Pharmaceutical Preparations

OnKure Therapeutics, Inc.

OKUR Clue Score34
United States Fiscal year ends December CIK 0001637715 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

61
Insider
Date
Role
Action
Shares
Price
Amount
Jason A. Leverone
21 Sep 2026
Chief Financial Officer
Sell
302
$2.97
$898.21
Nicholas A Saccomano
21 Sep 2026
President and CEO
Sell
87
$2.97
$258.76
Jason A. Leverone
22 Jun 2026
Chief Financial Officer
Sell
303
$4.40
$1.33K
Nicholas A Saccomano
22 Jun 2026
President and CEO
Sell
86
$4.40
$378.08
Jason A. Leverone
23 Mar 2026
Chief Financial Officer
Sell
301
$4.16
$1.25K
Nicholas A Saccomano
23 Mar 2026
President and CEO
Sell
86
$4.16
$357.46
Jason A. Leverone
22 Dec 2025
Chief Financial Officer
Sell
302
$2.97
$896.25
Nicholas A Saccomano
22 Dec 2025
President and CEO
Sell
87
$2.97
$258.19
Jason A. Leverone
22 Sep 2025
Chief Financial Officer
Sell
303
$2.62
$794.92
Nicholas A Saccomano
22 Sep 2025
President and CEO
Sell
88
$2.62
$230.87
Jason A. Leverone
23 Jun 2025
Chief Financial Officer
Sell
303
$2.38
$722.41
Nicholas A Saccomano
23 Jun 2025
President and CEO
Sell
88
$2.38
$209.81
Acorn Bioventures, L.p.
15 May 2025
10% owner
Buy indirect
1,129,730
$1.85
$2.09M
Acorn Bioventures, L.p.
15 May 2025
10% owner
Buy
270,270
$1.85
$500.00K
Cormorant Asset Management, LP
15 May 2025
Former 10% Owner
Sell indirect
1,813,439
$1.85
$3.36M
Cormorant Asset Management, LP
12 May 2025
10% owner
Sell indirect
24,300
$1.99
$48.24K
Jason A. Leverone
7 Apr 2025
Chief Financial Officer
Sell
1,844
$2.67
$4.93K
Nicholas A Saccomano
7 Apr 2025
President and CEO
Sell
516
$2.67
$1.38K
Jason A. Leverone
4 Apr 2025
Chief Financial Officer
Sell
1,278
$3.33
$4.25K
Nicholas A Saccomano
4 Apr 2025
President and CEO
Sell
358
$3.33
$1.19K
Braden Michael Leonard
25 Sep 2024
10% owner
Buy indirect
68,746
$1.50
$102.87K
Braden Michael Leonard
24 Sep 2024
10% owner
Buy indirect
29,600
$1.41
$41.87K
Braden Michael Leonard
18 Sep 2024
10% owner
Buy indirect
806
$1.40
$1.13K
Braden Michael Leonard
17 Sep 2024
10% owner
Buy indirect
55,300
$1.36
$75.11K
Braden Michael Leonard
16 Sep 2024
10% owner
Buy indirect
172,747
$1.37
$236.87K
Braden Michael Leonard
13 Sep 2024
10% owner
Buy indirect
150,000
$1.31
$196.95K
Braden Michael Leonard
12 Sep 2024
10% owner
Buy indirect
36,176
$1.40
$50.52K
Braden Michael Leonard
14 Aug 2024
10% owner
Buy indirect
100,487
$1.41
$142.01K
Braden Michael Leonard
13 Aug 2024
10% owner
Buy indirect
171,339
$1.39
$238.59K
Braden Michael Leonard
14 May 2024
10% owner
Buy indirect
335,000
$1.54
$515.90K
Braden Michael Leonard
14 May 2024
10% owner
Buy indirect
79,281
$1.56
$123.68K
Ashley Hall
28 Aug 2023
Chief Development Officer
Sold after exercise
15,625
$6.28
$98.06K
Novo Holdings A/S
23 Jun 2023
10% owner
Sell
100,000
$7.10
$709.74K
Niall O'Donnell
8 May 2023
Director
Buy indirect
125,000
$8.00
$1.00M
Michael Cruse
1 Sep 2022
Chief Operating Officer
Buy indirect
7,500
$3.39
$25.45K
Michael Cruse
31 Aug 2022
Chief Operating Officer
Buy indirect
3,212
$3.21
$10.31K
Michael G Grey
31 Aug 2022
Executive Chairman
Exercised, kept
50,000
$1.97
$98.50K
Michael Cruse
30 Aug 2022
Chief Operating Officer
Buy indirect
1,845
$3.19
$5.89K
Michael Cruse
30 Aug 2022
Chief Operating Officer
Buy
975
$3.16
$3.08K
Michael Cruse
29 Aug 2022
Chief Operating Officer
Buy indirect
1,140
$3.24
$3.69K
Michael Cruse
29 Aug 2022
Chief Operating Officer
Buy
83
$3.24
$268.92
Michael Cruse
25 Aug 2021
Senior VP-Corporate Operations
Buy
2,500
$7.45
$18.62K
Gregory J. Flesher
25 Aug 2021
President and CEO
Buy
8,000
$8.00
$64.00K
Vineet R. Jindal
25 Aug 2021
Chief Financial Officer
Buy
5,000
$7.44
$37.18K
Wendy S. Johnson
14 Jul 2021
Chief Development Officer
Sell
111,736
$8.50
$949.76K
Bali Muralidhar
14 Jul 2021
Director
Buy indirect
111,736
$8.50
$949.76K
Wendy S. Johnson
8 Jul 2021
Chief Development Officer
Exercised, kept
111,736
$1.97
$220.12K
Bali Muralidhar
23 Jun 2021
Director
Buy indirect
20,710
$9.28
$192.24K
Bali Muralidhar
22 Jun 2021
Director
Buy indirect
14,615
$8.72
$127.49K
Bali Muralidhar
21 Jun 2021
Director
Buy indirect
32,659
$9.03
$294.93K
Bali Muralidhar
8 Jun 2021
Director
Buy indirect
16,605
$9.50
$157.71K
Bali Muralidhar
4 Jun 2021
Director
Buy indirect
257
$9.42
$2.42K
Bali Muralidhar
3 Jun 2021
Director
Buy indirect
12,100
$9.25
$111.94K
Bali Muralidhar
28 May 2021
Director
Buy indirect
14
$9.50
$133.00
Bali Muralidhar
27 May 2021
Director
Buy indirect
1,120
$9.26
$10.37K
Bali Muralidhar
26 May 2021
Director
Buy indirect
5,915
$9.38
$55.50K
Novo Holdings A/S
13 Apr 2021
10% owner
Buy
666,666
$15.00
$10.00M
Bali Muralidhar
13 Apr 2021
Director
Buy indirect
200,000
$15.00
$3.00M
Niall O'Donnell
13 Apr 2021
Director
Buy indirect
200,000
$15.00
$3.00M
New Enterprise Associates 15, L.P.
13 Apr 2021
10% owner
Buy
666,666
$15.00
$10.00M
RiverVest Venture Fund III, L.P.
9 Apr 2021
10% owner
Buy indirect
200,000
$15.00
$3.00M

What was left out

Form 4 filings counted 133
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 13,328,761
Sales filed before the plan box existed 1
History held since 12 Apr 2021